William Fry’s Charleen O’Keeffe spoke to Siliconrepublic.com about the life sciences industry and the impacts of digital transformation.

As with all industries, digital transformation is changing how the life sciences industry works. Charleen O’Keeffe, a partner in William Fry’s life sciences group, said she’s seeing three major trends coming down the line.

“The first of these is the digitalisation in the healthcare sector. This is happening in many forms, for example increased use of telemedicine, AI-enabled medical devices and use of blockchain electronic medical records,” she said.

“The second big trend we are seeing is a move towards non-pharmacological intervention and the use of screening devices to screen for diseases and the treatment of chronic diseases.”

O’Keeffe said the third major trend is in relation to medicines. “We are seeing a shift away from the one-size-fits-all approach to personalised, individualised medicines.


Words by Jenny Darmody